Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4306240 | 0.69 | L3MBTL1 (0.42) | L3MBTL1 | |
| SCHEMBL15968357 | 0.65 | L3MBTL1 (0.38) | L3MBTL1 | |
| SCHEMBL18151138 | 0.65 | L3MBTL1 (0.38) | L3MBTL1 | |
| SCHEMBL10144354 | 0.65 | MEN1 (0.34) | L3MBTL1 | |
| SCHEMBL4312392 | 0.65 | KDM4E (0.41) | L3MBTL1 | |
| SCHEMBL10144348 | 0.64 | HTR2B (0.32) | — | |
| SCHEMBL16959585 | 0.63 | PTGDR2 (0.53) | L3MBTL1 | |
| SCHEMBL18149645 | 0.62 | NPY1R (0.39) | L3MBTL1 | |
| SCHEMBL3359233 | 0.62 | L3MBTL1 (0.36) | L3MBTL1 | |
| SCHEMBL869294 | 0.61 | MEN1 (0.39) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120077993-A1 | SPIRO EPOXIDES AS INTERMEDIATES | SYNGENTA CROP PROTECTION, LLC (US) | 2012-03-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120077993-A1 | SPIRO EPOXIDES AS INTERMEDIATES | CYP1A1, CYP2E1, CYP1B1 | L3MBTL1 4566/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.